ThinkEquity Starts Regeneron Pharma (REGN) at Buy, Sets $120 Price Target

February 3, 2012 7:51 AM EST Send to a Friend
Get Alerts REGN Hot Sheet
Price: $259.50 -1.57%

Rating Summary:
    12 Buy, 11 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 24
Trade REGN Now!
ThinkEquity initiates coverage on shares of Regeneron Pharma (NASDAQ: REGN) with a Buy rating and $120 price target.

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $95.01 yesterday, with a 52 week range of $33.57-$95.21.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

New Coverage

Related Entities

ThinkEquity

Add Your Comment